Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study.
Oncologist
; 24(11): 1424-1431, 2019 11.
Article
in En
| MEDLINE
| ID: mdl-31152079
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Receptors, Estrogen
/
Biomarkers, Tumor
/
Receptor, ErbB-2
/
Gene Expression Profiling
/
Clinical Decision-Making
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Oncologist
Journal subject:
NEOPLASIAS
Year:
2019
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom